Virtus ETF Advisers LLC Enanta Pharmaceuticals Inc Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$11.09 - $22.13 $18,342 - $36,603	-1,654 Reduced 11.46%	12,784 $142,000
Q2 2023 Aug 14, 2023	BUY	$20.68 - $39.85 $155,389 - $299,432	7,514 Added 108.52%	14,438 $308,000
Q1 2023 May 15, 2023	BUY	$38.82 - $54.59 $4,813 - $6,769	124 Added 1.82%	6,924 $280,000
Q4 2022 Feb 14, 2023	BUY	$40.77 - $53.73 $37,386 - $49,270	917 Added 15.59%	6,800 $316,000
Q3 2022 Nov 14, 2022	BUY	$48.29 - $71.27 $4,104 - $6,057	85 Added 1.47%	5,883 $305,000
Q2 2022 Aug 12, 2022	BUY	$38.13 - $76.93 $16,967 - $34,233	445 Added 8.31%	5,798 $274,000
Q4 2021 Feb 14, 2022	SELL	$60.19 - $97.37 $255,566 - $413,433	-4,246 Reduced 44.23%	5,353 $400,000
Q3 2021 Nov 15, 2021	SELL	$41.02 - $58.65 $36,261 - $51,846	-884 Reduced 8.43%	9,599 $545,000
Q2 2021 Aug 10, 2021	SELL	$43.76 - $53.11 $185,454 - $225,080	-4,238 Reduced 28.79%	10,483 $461,000
Q1 2021 May 17, 2021	BUY	$41.69 - $54.95 $16,676 - $21,980	400 Added 2.79%	14,721 $726,000
Q4 2020 Feb 12, 2021	BUY	$41.16 - $47.47 $93,638 - $107,994	2,275 Added 18.89%	14,321 $603,000
Q3 2020 Nov 13, 2020	BUY	$43.36 - $53.53 $44,010 - $54,332	1,015 Added 9.2%	12,046 $551,000
Q2 2020 Aug 05, 2020	BUY	$46.37 - $57.58 $102,014 - $126,676	2,200 Added 24.91%	11,031 $554,000
Q1 2020 May 14, 2020	SELL	$40.22 - $62.0 $29,963 - $46,190	-745 Reduced 7.78%	8,831 $454,000
Q4 2019 Feb 13, 2020	BUY	$57.95 - $66.61 $86,751 - $99,715	1,497 Added 18.53%	9,576 $592,000
Q3 2019 Nov 12, 2019	SELL	$60.08 - $88.17 $81,348 - $119,382	-1,354 Reduced 14.35%	8,079 $485,000
Q2 2019 Aug 13, 2019	SELL	$81.3 - $97.35 $97,641 - $116,917	-1,201 Reduced 11.29%	9,433 $796,000
Q1 2019 May 14, 2019	BUY	$69.08 - $105.66 $172,285 - $263,516	2,494 Added 30.64%	10,634 $1.02 Million
Q4 2018 Feb 05, 2019	BUY	$65.41 - $84.65 $71,166 - $92,099	1,088 Added 15.43%	8,140 $577,000
Q3 2018 Nov 14, 2018	BUY	$85.46 - $126.37 $40,593 - $60,025	475 Added 7.22%	7,052 $603,000
Q2 2018 Aug 10, 2018	SELL	$81.85 - $120.51 $739,596 - $1.09 Million	-9,036 Reduced 57.87%	6,577 $762,000
Q1 2018 May 14, 2018	SELL	$57.91 - $92.15 $111,071 - $176,743	-1,918 Reduced 10.94%	15,613 $1.26 Million
Q4 2017 Feb 14, 2018	SELL	$45.65 - $59.37 $671,237 - $872,976	-14,704 Reduced 45.62%	17,531 $1.03 Million
Q2 2017 Aug 14, 2017	BUY	N/A	32,235	32,235 $1.16 Million

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$19.7 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$18.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$17.3 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$14 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$10.3 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account